These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28906259)
1. Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand? Reznik E; Smith AW; Taube S; Mann J; Yondorf MZ; Parashar B; Wernicke AG Am J Clin Oncol; 2018 Feb; 41(2):197-212. PubMed ID: 28906259 [TBL] [Abstract][Full Text] [Related]
3. A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial. Rapp M; Grauer OM; Kamp M; Sevens N; Zotz N; Sabel M; Sorg RV Trials; 2018 May; 19(1):293. PubMed ID: 29801515 [TBL] [Abstract][Full Text] [Related]
4. The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists. Burri SH; Gondi V; Brown PD; Mehta MP Am J Clin Oncol; 2018 Feb; 41(2):191-196. PubMed ID: 28832384 [TBL] [Abstract][Full Text] [Related]
5. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base. Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053 [TBL] [Abstract][Full Text] [Related]
6. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population. Haque W; Verma V; Butler EB; Teh BS Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825 [TBL] [Abstract][Full Text] [Related]
7. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. Carlson JA; Reddy K; Gaspar LE; Ney D; Kavanagh BD; Damek D; Lillehei K; Chen C J Neurooncol; 2015 Jun; 123(2):251-7. PubMed ID: 25920710 [TBL] [Abstract][Full Text] [Related]
8. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review. Ashby LS; Smith KA; Stea B World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526 [TBL] [Abstract][Full Text] [Related]
9. Survival improvements with adjuvant therapy in patients with glioblastoma. Jayamanne D; Wheeler H; Cook R; Teo C; Brazier D; Schembri G; Kastelan M; Guo L; Back MF ANZ J Surg; 2018 Mar; 88(3):196-201. PubMed ID: 28922698 [TBL] [Abstract][Full Text] [Related]
10. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial. Cho DY; Yang WK; Lee HC; Hsu DM; Lin HL; Lin SZ; Chen CC; Harn HJ; Liu CL; Lee WY; Ho LH World Neurosurg; 2012; 77(5-6):736-44. PubMed ID: 22120301 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493 [TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival. dos Santos MA; Pignon JP; Blanchard P; Lefeuvre D; Levy A; Touat M; Louvel G; Dhermain F; Soria JC; Deutsch E; Le Teuff G J Neurooncol; 2015 Jun; 123(2):307-14. PubMed ID: 25975195 [TBL] [Abstract][Full Text] [Related]
15. PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244. Elinzano H; Glantz M; Mrugala M; Kesari S; Piccioni DE; Kim L; Pan E; Yunus S; Coyle T; Timothy K; Evans D; Mantripragada K; Boxerman J; DiPetrillo T; Donahue JE; Hebda N; Mitchell KM; Rosati KL; Safran H Am J Clin Oncol; 2018 Feb; 41(2):159-162. PubMed ID: 26658237 [TBL] [Abstract][Full Text] [Related]